Category: Research & Development

  • Medicinal Cannabis Science Conference in Toronto

    Medicinal Cannabis Science Conference in Toronto

    March 1st, 2018 — For those in the cannabis industry interested in the very latest scientific developments they will want to consider attending the upcoming Medicinal Cannabis Conference being held in Toronto, March 23 – 24, 2018, hosted by the International Pharmaceutical Academy at the DoubleTree by Hilton Toronto Downtown. This two-day conference will feature 10 of…

  • GW Pharma Completes Epidiolex® New Drug Application

    GW Pharma Completes Epidiolex® New Drug Application

    October 30th, 2017 – GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Completes Rolling New Drug Application Submission to U.S. Food and Drug Administration for Epidiolex® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome and Dravet Syndrome. GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from…

  • Canada: Predictions for a $1-Billion Hemp Industry

    Canada: Predictions for a $1-Billion Hemp Industry

    August 12th, 2017 – A Vegreville Alberta research centre is on the cutting edge of a booming Canadian hemp industry one scientist predicts will be worth $1 billion annually within a few years. That’s roughly five times the industrial hemp industry’s current approximately $200-million value, but InnoTech Alberta’s Jan Slaski says the business is poised…

  • Rigorous Study Shows CBD Reduces Epileptic Seizures in Children

    Rigorous Study Shows CBD Reduces Epileptic Seizures in Children

    May 31st, 2017 – Medical researchers have confirmed what some desperate parents have been claiming for years—that a nonpsychoactive component of marijuana known as cannabidiol (CBD) can reduce epileptic seizures in some children. Published in The New England Journal of Medicine, the findings stem from a double-blind, placebo-controlled study—the most scientifically rigorous type of investigation possible.…

  • Kentucky University Researches Hemp BioFuel Potential

    Kentucky University Researches Hemp BioFuel Potential

    May 17th, 2017 – The University of Louisville’s Conn Center for Renewable Energy is planting more hemp this year at the school’s Belknap Campus. This is officially the center’s second hemp crop — the first was planted last August and yielded a few dozen pounds of plants. This year, there will be two different varieties of…

  • Milestone Study Shows Patients Swapping Pharmaceuticals for Cannabis

    Milestone Study Shows Patients Swapping Pharmaceuticals for Cannabis

    April 7th, 2017 – TORONTO, ON – (April 7, 2017) – Today, Canabo Medical Inc. (TSX-V:CMM) (OTCQB:CAMDF) (“Canabo” or the “Company”) released the results of a new, landmark observational study that connects doctor-supervised medical cannabis treatments to a sharp drop in benzodiazepine reliance among Canadian patients. Research conducted over the past year revealed that 40 per…

  • Study: Cannabidiol is Safe, Effective for Childhood Epilepsy

    Study: Cannabidiol is Safe, Effective for Childhood Epilepsy

    May 14, 2015 – A recent study conducted at New York University has found that cannabidiol is a safe, well-tolerated and effective treatment for two types of severe childhood epilepsy. Cannabidiol (CBD) is an endocannabinoid found in cannabis and can be sourced either from medical marijuana or industrial hemp. CBD does not deliver a psychoactive…

  • Colorado Lab Settles in $100 Million Lawsuit with Medical Marijuana Inc.

    Colorado Lab Settles in $100 Million Lawsuit with Medical Marijuana Inc.

    April 27th, 2015 – As part of a $100 million lawsuit filed by Medical Marijuana Inc., over false claims in a “special report” from Project CBD, a top Colorado lab, Stewart Environmental has now settled. Dr. Stuart Titus, CEO and President of Medical Marijuana, Inc. said: “Now that Medical Marijuana, Inc. has proven the claims…

  • Study: Cannabidiol has Potential to Treat Diabetes

    Study: Cannabidiol has Potential to Treat Diabetes

    April 24th, 2015 – Researchers at the Hebrew University of Jerusalem, led by Dr. Raphael Mechoulam, who is known for discovering cannabidol (CBD), conducted a study that suggests that the therapeutic effects of Cannabidiol (CBD), a non-psychoactive compound, could be modified to fit different receptors. Different illness such as diabetes, atherosclerosis and cardiovascular disease could…

  • Dr. Sanjay Gupta: “It’s Time for a Medical Marijuana Revolution”

    Dr. Sanjay Gupta: “It’s Time for a Medical Marijuana Revolution”

    April 17th, 2015 – A year ago CNN’s Dr. Sanjay Gupta created a media sensation and surge of interest in medical marijuana with the release of his documentary series Weed 1 & 2. In these previous segments, Dr. Gupta apologized for his previous negative stand on the merits of medical marijuana, admitting that he had…